Member Info for Fruitsnveg

Do you think that's why Mani & Co are trying to dominate the bb with their incessant yapping and yelping? I think the 2 are related. Is it just me?

"Someone's buying a lot of shares. .... They want to keep the share price low for the bounce on an RNS and then sell."

This.

2 words; pi$s up. Brewery.

Just decided to come back on here to warn you about "greed" and the perils of AIM, Aether, for no apparent reason. Just happened to swing by with the other dozen poppets. Nothing in it. All coincidence. Just warning you. In case you get any daft ideas about buying more shares. Because just no. Got it?!?

Lolz

Que sera, sera. The eventual stop on Recovery funding was known some time ago. All good things come to an end. But don't be misled into thinking that old Blightly isn't pushing forwards into a new age of Bio-innovation. Pioneering initiatives like Genomics England and the UK Biobank have already become world leaders. And as we know British scientists showed their excellence in responding to the Covid-19 pandemic and will continue to do so on may other initiatves. There are some exciting things coming thinks our government; https://www.gov.uk/government/news/biotech-driving-medical-breakthroughs-and-cuts-to-red-tape-lead-major-science-and-tech-package-to-spark-uk-innovation-and-growth. Many reasons to be optimistic and look forwards, not back.

Lol

To$$.er

Who told you they didn't collect samples?

No need to be so miserable DocDan. Just facts, nothing to be afraid of. Any investor would be thrilled with the knowledge that SNG001 is not reliant on any one venue, but multiple indications. Derisked investment; I would have thought you'd be thrilled?

DocDan,

I's not really an issue - we are now a specialist respiratory biotech company whose primary focus is developing our investigative inhaled interferon beta (IFN-β) for the treatment of severe viral lung infections as potentially the first host-directed, broad-spectrum antiviral treatment delivered directly into the lungs. We've moved on from being a Covid-centric treatment, which is great, given your analysis of the current Covid landscape.

The never ending drama.

If you don't have health insurance in America you need to access the 'Bridge Access Program' to get the vaccine for free. Importantly - that programme will end on December 31, 2024, so any governmental aid is essentially temporary.

The Biden Administration has not guaranteed to extend it beyond that date, and if the fake-tanned one somehow wrangles his way out of 96 endictments and back into the Oval office, then you can probably say, with a fair amount of certainty, that a 2nd Trump Administration won't spend a dime on anything remotely in the interests of public health. So this time next year, those 25-30 million uninsured could be looking at $100+ for vaccine, then there's the follow-up boosters necessitated because of variant changes, etc. Unless you think Covid is going o magically disappear as the orange one does, that cost is going to be hanging over them until the day they die, and for a family that cost is not negligible.

So yes, there will always be a target group for an antiviral like SNG001.

The article fails to address, or addresses too likely imo, the most likely causes, namely being one of cost (Americans now have to pay out of pocket fr vaccinations and it's not a cheap recurring expense for the majority of whom live paycheck to paycheck), the prevalence of auto-abs in the population (rendering other precautions less successful), and continued widespread misinformation on vaccines and treatments.

When you knowingly throw out misleading pricing information, expect it to be called out as inaccurate. Facts matter, as you well know.

I think you need to take a break DocDan. You are wittering on about something I don't recognise. Perhaps it is your perception of reality that is skewed?

Another deranged, not to mention deeply inaccurate and slanderous post that merits little attention.

The only thing that is "perverse" here, is your warped fixation with untruths.

Price comparisons to any Covid-only drug is immaterial. It's apples and pears, whatever way you slice it.

"of all the outpatient drugs you listed SNG was the most expensive by a factor of at least 7."

A wholly misleading statement, but moreover, a very moot point, because SNG001 is destined for inpatients, not for mild outpatient cases who would take those drugs.

Very much apples and pears.

...And yes, I've mixed up my Paxlovid with my Molnupiravir. Silly me. No shoot!

However, latest research remains valid - even though there are treatments for Covid, research is still uncovering weaknesses in those and new treatments are still needed.

But the